Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement
- PMID: 31550038
- DOI: 10.1001/jama.2019.13069
Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: Among the general adult population, women (across all ages) have the highest prevalence of asymptomatic bacteriuria, although rates increase with age among both men and women. Asymptomatic bacteriuria is present in an estimated 1% to 6% of premenopausal women and an estimated 2% to 10% of pregnant women and is associated with pyelonephritis, one of the most common nonobstetric reasons for hospitalization in pregnant women. Among pregnant persons, pyelonephritis is associated with perinatal complications including septicemia, respiratory distress, low birth weight, and spontaneous preterm birth.
Objective: To update its 2008 recommendation, the USPSTF commissioned a review of the evidence on potential benefits and harms of screening for and treatment of asymptomatic bacteriuria in adults, including pregnant persons.
Population: This recommendation applies to community-dwelling adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection.
Evidence assessment: Based on a review of the evidence, the USPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria in pregnant persons has moderate net benefit in reducing perinatal complications. There is adequate evidence that pyelonephritis in pregnancy is associated with negative maternal outcomes and that treatment of screen-detected asymptomatic bacteriuria can reduce the incidence of pyelonephritis in pregnant persons. The USPSTF found adequate evidence of harms associated with treatment of asymptomatic bacteriuria (including adverse effects of antibiotic treatment and changes in the microbiome) to be at least small in magnitude. The USPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria in nonpregnant adults has no net benefit. The known harms associated with treatment include adverse effects of antibiotic use and changes to the microbiome. Based on these known harms, the USPSTF determined the overall harms to be at least small in this group.
Recommendations: The USPSTF recommends screening pregnant persons for asymptomatic bacteriuria using urine culture. (B recommendation) The USPSTF recommends against screening for asymptomatic bacteriuria in nonpregnant adults. (D recommendation).
Comment in
-
Updated Guidelines for Screening for Asymptomatic Bacteriuria.JAMA. 2019 Sep 24;322(12):1152-1154. doi: 10.1001/jama.2019.11640. JAMA. 2019. PMID: 31550011 No abstract available.
-
USPSTF recommends screening for asymptomatic bacteriuria in pregnant women but not nonpregnant adults.Ann Intern Med. 2020 Feb 18;172(4):JC14. doi: 10.7326/ACPJ202002180-014. Ann Intern Med. 2020. PMID: 32066147 No abstract available.
-
Re: Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement.J Urol. 2020 Oct;204(4):859-860. doi: 10.1097/JU.0000000000001209. Epub 2020 Jul 23. J Urol. 2020. PMID: 32703066 No abstract available.
Summary for patients in
-
Screening for Asymptomatic Bacteriuria.JAMA. 2019 Sep 24;322(12):1222. doi: 10.1001/jama.2019.14876. JAMA. 2019. PMID: 31550033 No abstract available.
Similar articles
-
Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2019 Sep 24;322(12):1195-1205. doi: 10.1001/jama.2019.10060. JAMA. 2019. PMID: 31550037
-
Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement.JAMA. 2020 Apr 7;323(13):1286-1292. doi: 10.1001/jama.2020.2684. JAMA. 2020. PMID: 32259236
-
Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.JAMA. 2019 Jun 18;321(23):2326-2336. doi: 10.1001/jama.2019.6587. JAMA. 2019. PMID: 31184701
-
Screening for Asymptomatic Bacteriuria in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Sep. Report No.: 19-05252-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Sep. Report No.: 19-05252-EF-1. PMID: 31573774 Free Books & Documents. Review.
-
Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement.Ann Intern Med. 2008 Jul 1;149(1):W20-4. doi: 10.7326/0003-4819-149-1-200807010-00009-w1. Ann Intern Med. 2008. PMID: 18591632 Review.
Cited by
-
Current and emerging strategies to curb antibiotic-resistant urinary tract infections.Nat Rev Urol. 2024 Dec;21(12):707-722. doi: 10.1038/s41585-024-00877-9. Epub 2024 May 7. Nat Rev Urol. 2024. PMID: 38714857 Review.
-
Educational Case: Acute Cystitis.Acad Pathol. 2020 Sep 10;7:2374289520951923. doi: 10.1177/2374289520951923. eCollection 2020 Jan-Dec. Acad Pathol. 2020. PMID: 32974422 Free PMC article.
-
Prevalence of Asymptomatic Bacteriuria (ASB) in Pregnant Women in India: A Systematic Review and Meta-Analysis.Indian J Community Med. 2023 Nov-Dec;48(6):879-887. doi: 10.4103/ijcm.ijcm_795_22. Epub 2023 Dec 1. Indian J Community Med. 2023. PMID: 38249695 Free PMC article.
-
Analysis of an Antibiotic Stewardship Program for Asymptomatic Bacteriuria in the Veterans Affairs Health Care System.JAMA Netw Open. 2022 Jul 1;5(7):e2222530. doi: 10.1001/jamanetworkopen.2022.22530. JAMA Netw Open. 2022. PMID: 35877123 Free PMC article.
-
D-mannose for preventing and treating urinary tract infections.Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD013608. doi: 10.1002/14651858.CD013608.pub2. Cochrane Database Syst Rev. 2022. PMID: 36041061 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical